Literature DB >> 17898331

Olanzapine and pediatric bipolar disorder: evidence for efficacy and safety concerns.

Jon M McClellan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17898331     DOI： 10.1176/appi.ajp.2007.07071148

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN： 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  4 in total

1.  Multiple psychiatric diagnoses common in privately insured children on atypical antipsychotics.

Authors:  Donna R Halloran; Jason Swindle; Steve K Takemoto; Mark A Schnitzler
Journal:  Clin Pediatr (Phila)       Date:  2010-01-28       Impact factor: 1.168

2.  Bringing a research base to psychiatry.

Authors:  Miriam Shuchman; Paul C Hébert; Rajendra Kale; Barbara Sibbald; Ken Flegel; Noni MacDonald
Journal:  CMAJ       Date:  2008-05-06       Impact factor: 8.262

Review 3.  [Off-label use in child and adolescent psychiatry. An ongoing ethical, medical and legal problem].

Authors:  M Kölch; M Allroggen; J M Fegert
Journal:  Nervenarzt       Date:  2009-07       Impact factor: 1.214

Review 4.  Early intervention in bipolar disorder, part II: therapeutics.

Authors:  Giacomo Salvadore; Wayne C Drevets; Ioline D Henter; Carlos A Zarate; Husseini K Manji
Journal:  Early Interv Psychiatry       Date:  2008-08       Impact factor: 2.732
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.